MISSION VIEJO, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) announced today financial results for the three months ended March 31, 2011. The Company reported net income of approximately $3,778,000, or $0.06 per share (undiluted), which includes a non-cash adjustment of approximately $4,746,000 related to decreases in the fair value of warrants that are included as a component of other income (expenses) in the statement of operations, for the three months ended March 31, 2011, compared to net income of $6,918,000, or $0.14 per share (undiluted), which includes a non-cash adjustment of approximately $7,817,000 related to decreases in the fair value of warrants that are included as a component of other income (expenses) in the statement of operations, for the three months ended March 31, 2010.
